@prefix this: <https://w3id.org/np/RAQtej8ruymQDRyohVoSiI9uCQa6AsNuN0qmaoGZkmHZ4> .
@prefix sub: <https://w3id.org/np/RAQtej8ruymQDRyohVoSiI9uCQa6AsNuN0qmaoGZkmHZ4/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  sub:researchproject a <https://schema.org/ResearchProject>;
    dct:description "Antimicrobial resistance is one of the major human health threats of this century. Therefore, the NACTAR-programme focuses on research into new resources for antibiotics and alternatives to antibiotics. Preclinical validation is also part of the research programme, so that the new antibiotics or alternative therapies become available and accessible for healthcare at a fair and affordable price. (https://www.nwo.nl/en/researchprogrammes/novel-antibacterial-compounds-and-therapies-antagonising-resistance-nactar)";
    rdfs:label "NACTAR programme";
    rdfs:seeAlso <https://www.nwo.nl/en/researchprogrammes/novel-antibacterial-compounds-and-therapies-antagonising-resistance-nactar>;
    <https://schema.org/endDate> "2023";
    <https://schema.org/funder> <https://ror.org/04jsz6e67>;
    <https://schema.org/startDate> "2017";
    <https://w3id.org/fair/fip/terms/has-research-domain> <http://edamontology.org/topic_3370>,
      <http://purl.obolibrary.org/obo/NCIT_C16414>, <http://www.fairsharing.org/ontology/subject/SRAO_0000097>;
    <https://www.w3.org/TR/owl-ref/#sameAs-def> "Project number 16439" .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0003-3837-6137, <https://ror.org/027bh9e22> .
}

sub:pubinfo {
  this: dct:created "2025-09-19T13:43:28.439Z"^^xsd:dateTime;
    dct:creator orcid:0000-0003-3837-6137;
    dct:license <https://creativecommons.org/licenses/by/4.0/>;
    npx:hasNanopubType <https://schema.org/ResearchProject>;
    npx:introduces sub:researchproject;
    npx:wasCreatedAt <https://nanodash.knowledgepixels.com/>;
    nt:wasCreatedFromProvenanceTemplate <https://w3id.org/np/RAW4qDSeYWgZwQDIPBOKlaCoSQiLZeavVCNsJMCcpU3kY>;
    nt:wasCreatedFromPubinfoTemplate <https://w3id.org/np/RA0J4vUn_dekg-U1kK3AOEt02p9mT2WO03uGxLDec1jLw>,
      <https://w3id.org/np/RAukAcWHRDlkqxk7H2XNSegc1WnHI569INvNr-xdptDGI>;
    nt:wasCreatedFromTemplate <https://w3id.org/np/RAxZ8oT8CuDFBHelrkt-f2jpkSPWHqUwbs10cAx8B5yck> .
  
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEA0n6evU1FvEZTSki0U1ZZonP4fbkMNqtRoJc6a03a336t35TFlOuNj64m2syxUS52+RCaC2HsR2f4JH+MEtljAGiuOEqXa2kD/REWpS+eNMxKnm7cAP42cvwoMTZ2/VHSA/lfxcXjEpP5LanZNJKpZjafanbHiJiiJdRXkqh0Mc68YLCD7joKwCR+f9YRphtNJx4mmt0Ibm3niXPB5SpQ+1sd2IaW2EnMPoPMf5hwYz5pwBDe4KGB0zmfCxwH2Kb+DQsBTrjOVwhr5wKYYTNmR5w1P2MREbnomZTaD8OwhbI9SSyA1ZFfGO2K1brfKFr6mvkgRv1A+ltcF2fQwBo3ZQIDAQAB";
    npx:hasSignature "waUFURnuCppRhgn/DAgVp4jIYM//OcnMZbM6E3PvI0pEytdTvwNCDkKRhacxCRCrjAX3egVfpDUZouU2bNzl3zbGfSkXypllXepMT7ouLvmC4GEB1+yEGY1yPi7sQKLXuLbTvSZ2NO7/cyjUp3z50iJ9JFBKDgSuYtsawOR9t8GRITSYKYn4CMLz/g4Ghr+ulEP4oA9vc2eFVqWJccBe6VpuHPpMA+DZAMog5Xgbb/o9z3g32orwiuLLENTX4gTgXQ8I0NdtvK+2D9HiL38XRmn2L/QIHGl02Ofn3TnqnM5joaC/ouwiO0eMSp0gxbYKp+hdz5BnqoTMsCeGg46mlw==";
    npx:hasSignatureTarget this:;
    npx:signedBy orcid:0000-0003-3837-6137 .
}